NCT01659385 (LL-PTC) is a clinical trial in Thyroid Cancer, Papillary, sponsored by University of Nebraska.

Who is sponsoring NCT01659385?

NCT01659385 is sponsored by University of Nebraska.

What condition does NCT01659385 study?

NCT01659385 studies Thyroid Cancer, Papillary, Leptin Levels.

Is NCT01659385 still recruiting?

NCT01659385 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT01659385: LL-PTC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Leptin Levels in Papillary Thyroid Cancer

Completed Last updated 6 September 2023

What this trial tests

trial in Thyroid Cancer, Papillary in 18 participants. Completed in 25 April 2013.

Timeline

7 August 2012

Primary endpoint
25 April 2013

25 April 2013

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	18
Start date	7 August 2012
Primary completion	25 April 2013
Estimated completion	25 April 2013
Sites	1 location across United States

Conditions studied

Thyroid Cancer, Papillary — all drugs for Thyroid Cancer, Papillary →
Leptin Levels — all drugs for Leptin Levels →

Sponsor

University of Nebraska

Who can join

Adults 19 to 75, female only, with Thyroid Cancer, Papillary or Leptin Levels. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Thyroid Cancer, Papillary

Currently open trials in the same condition.

NCT06730321 — Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment · recruiting
NCT06254859 — Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery · recruiting
NCT06725576 — Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma · recruiting

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01659385 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01659385.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing